Examining Iron Metabolism in Hemodialysis Patients
Official title: Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients
Run by GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT05586867 · Data updated 2026-11-12
This study looks at how iron works in the bodies of people on hemodialysis to see how it relates to their overall health and other important minerals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche Academic / other |
| Locations | 1 site (Quincy-sous-Sénart) |
| Status | Recruiting |
| Started | December 1, 2021 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2031 |
| Registry record updated | October 19, 2022 |
| Trial ID | NCT05586867 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adult patients undergoing hemodialysis who can provide informed consent.
✕Probably not a fit
Patients who are medically unstable, have severe anemia, or are participating in other conflicting clinical studies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the metabolism of iron in patients undergoing hemodialysis, focusing on the evolution of specific biomarkers such as hepcidin and erythroferrone. It will explore how these biomarkers relate to calcium phosphate metabolism, hepatic metabolism, and inflammation. By analyzing blood samples, the study seeks to provide insights into the conditions affecting iron absorption, metabolism, and storage in patients with advanced renal failure.
Why it matters
Potential benefit: If successful, this study could improve the understanding of iron metabolism in hemodialysis patients, potentially leading to better management of related complications.
How similar studies have gone: While the specific biomarkers studied may not be routinely assessed, similar studies have indicated the importance of understanding iron metabolism in chronic kidney disease, suggesting potential for meaningful insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult dialysis patient * Patient able to understand the information necessary for the study and having signed his written consent to participate * Affiliated patient or beneficiary of a social security scheme. Exclusion Criteria: * Medically unstable or frail patient * Patient with hemoglobin less than 7g/dl * Patient with HIV+ or AIDS, patient with replicating hepatitis B or C * Patient participating in another clinical study requiring an additional blood sample * Patient benefiting from legal protection measures (guardianship, guardianship, etc.) adult under guardianship, guardianship or other legal protection, deprived of freedom by judicial or administrative decision * Pregnant, breastfeeding or parturient woman
Where it's running
-
Hôpital Privé Claude Galien
Quincy-sous-Sénart, France Recruiting
Study contacts
- Study coordinator: Jean-François Oudet
- Email: jeanfrancois.oudet@free.fr
- Phone: 0683346567
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease
This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.
-
Progressive muscle relaxation to ease depression and fatigue during hemodialysis
This trial will try whether guided progressive muscle relaxation can reduce depression and fatigue in people receiving hemodialysis.
-
Changing magnesium and acid type in dialysis fluid to reduce clotting and immune activation
This project tests whether changing the magnesium level and acid type in dialysis fluid can reduce immune-driven clotting and inflammation in people on maintenance hemodialysis.
-
Vericiguat for people with heart failure and chronic kidney disease on dialysis
This study will try vericiguat in adults with chronic kidney disease who are on dialysis and have heart failure with reduced ejection fraction to see how it works and how well patients tolerate it.
-
Exploring the effects of postbiotics on elderly hemodialysis patients
This study is testing if a new postbiotics product can improve the quality of life and nutrition for elderly patients on hemodialysis.
-
Platform for Rare Blood Disorders in Europe
This study is trying to gather and share information about rare blood disorders across Europe to help researchers understand these conditions better and improve treatment options for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.